Clinical Trial Update: Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases) [Phase 2, Phase 3]

View source ↗

Summary

An ongoing comparator-controlled trial (BROKE) is testing EGFR-mutant non-small cell lung cancer patients with multiple brain metastases in Phase 2/Phase 3. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Non-Small Cell Lung Cancer, Brain Metastases | Phase 2, Phase 3 | Status: UNKNOWN